Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| UTI Healthcare Fund-Growth Option- Direct | 318.6 | 3.00% | 4.76% | -0.84% | 21.87% | 80.30% | 107.79% | 2025-06-26 |
| SBI Healthcare Opportunities Fund Direct Growth | 486.9 | 1.86% | 3.73% | -0.38% | 21.24% | 71.57% | 119.80% | 2025-06-26 |
| UTI Healthcare Fund Regular Plan Growth | 282.8 | 2.91% | 4.48% | -1.35% | 20.65% | 76.76% | 101.63% | 2025-06-26 |
| SBI Healthcare Opportunities Fund Regular Growth | 425.4 | 1.77% | 3.46% | -0.89% | 19.97% | 67.99% | 112.89% | 2025-06-26 |
| Nippon India Pharma Fund - Direct Plan - Growth Plan | 570.4 | 2.44% | 5.02% | 0.37% | 16.38% | 70.01% | 101.69% | 2025-06-26 |
| Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl | 34.6 | 0.99% | 3.53% | -2.87% | 15.65% | 72.73% | 101.75% | 2025-06-26 |
| Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl | 34.6 | 0.99% | 3.53% | -2.87% | 15.65% | 72.73% | 101.75% | 2025-06-26 |
| Tata India Pharma & Healthcare Fund Direct Growth | 34.6 | 0.99% | 3.53% | -2.87% | 15.65% | 72.73% | 101.75% | 2025-06-26 |
| Nippon India Pharma Fund - Growth | 512.4 | 2.35% | 4.78% | -0.08% | 15.34% | 66.97% | 96.34% | 2025-06-26 |
| Tata India Pharma & Healthcare Fund Regular Payout of Inc Dist cum Cap Wdrl | 29.8 | 0.88% | 3.12% | -3.63% | 13.94% | 67.76% | 93.00% | 2025-06-26 |
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | 29.8 | 0.88% | 3.12% | -3.63% | 13.94% | 67.76% | 93.00% | 2025-06-26 |
| Tata India Pharma & Healthcare Fund Regular Growth | 29.8 | 0.88% | 3.12% | -3.63% | 13.94% | 67.76% | 93.00% | 2025-06-26 |